Abiopharma

CAPITAL SOUTHWEST CORP (CSWC)

Symbol	CSWC
Name	CAPITAL SOUTHWEST CORP
Sector	CONSUMER DISCRETIONARY
Region	North America
Industry	Textiles
Address	8333 DOUGLAS AVE, DALLAS, TX 75225
Telephone	2142385700
Fax	—
Email	—
Website	https://www.capitalsouthwest.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000017313
Description	Capital Southwest Corp is an us-based investment company that specializes in providing customized financing to middle market companies across various industries. The companys investment objective to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnership with business owners, management teams, and financial sponsors. The companys portfolio may include senior debt, second lien and subordinated debt, preferred stock and common stock and warrants. The primary source companys revenue comprises of interest income and dividend income from investments made as well as management fees. Additional info from NASDAQ: Capital Southwest Corp is an us-based investment company that specializes in providing customized financing to middle market companies across various industries. The companys investment objective to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnership with business owners, management teams, and financial sponsors. The companys portfolio may include senior debt, second lien and subordinated debt, preferred stock and common stock and warrants. The primary source companys revenue comprises of interest income and dividend income from investments made as well as management fees.

2026-08-03 20:01

Capital Southwest Announces Financial Results for First Fiscal Quarter Ended June 30, 2026

2026-07-30 17:01

New Form DEFA14A - CAPITAL SOUTHWEST CORP Filed: 2026-07-30 AccNo: 0000017313-26-000087 Size: 804 KB

2026-07-22 21:26

(99% Neutral) CAPITAL SOUTHWEST CORP (CSWC) Announces Regulatory Update

2026-07-16 20:04

(99% Neutral) CAPITAL SOUTHWEST CORP (CSWC) Reports Q3 2026 Financial Results

2026-07-15 17:58

New Form DEFA14A - CAPITAL SOUTHWEST CORP Filed: 2026-07-15 AccNo: 0000017313-26-000080 Size: 11 KB

2026-07-06 17:39

New Form DEFA14A - CAPITAL SOUTHWEST CORP Filed: 2026-07-06 AccNo: 0000017313-26-000077 Size: 307 KB

2026-07-06 17:38

New Form DEFA14A - CAPITAL SOUTHWEST CORP Filed: 2026-07-06 AccNo: 0000017313-26-000076 Size: 483 KB

2026-06-11 17:18

New Form DEFA14A - CAPITAL SOUTHWEST CORP Filed: 2026-06-11 AccNo: 0000017313-26-000070 Size: 436 KB

2026-06-10 22:33

Weinstein Joshua S. 🟡 adjusted position in 79.1K shares of CAPITAL SOUTHWEST CORP (CSWC) at $23.54 Transaction Date: Jun 09, 2026 | Filing ID: 000067

2026-06-10 20:56

Director Sarner Michael Scott 🟡 adjusted position in 114.5K shares of CAPITAL SOUTHWEST CORP (CSWC) at $23.54 Transaction Date: Jun 09, 2026 | Filing ID: 000064